US1423391002 - Common Stock

Overall **CSL** gets a fundamental rating of **5** out of 10. We evaluated **CSL** against 45 industry peers in the **Building Products** industry. Both the health and profitability get an excellent rating, making **CSL** a very profitable company, without any liquidiy or solvency issues. **CSL** has a expensive valuation and it also scores bad on growth.

Of the past 5 years **CSL** 4 years were profitable.

With a decent **Return On Invested Capital** value of **14.61%**, **CSL** is doing good in the industry, outperforming **64.44%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **CSL** is below the industry average of **15.47%**.

The last **Return On Invested Capital** (**14.61%**) for **CSL** is above the 3 year average (**10.67%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 12.28% | ||

ROE | 28.63% | ||

ROIC | 14.61% |

ROA(3y)8.01%

ROA(5y)8.84%

ROE(3y)19.71%

ROE(5y)20.08%

ROIC(3y)10.67%

ROIC(5y)10.37%

In the last couple of years the **Profit Margin** of **CSL** has grown nicely.

Looking at the **Operating Margin**, with a value of **18.30%**, **CSL** is in the better half of the industry, outperforming **75.56%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **CSL** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 18.3% | ||

PM (TTM) | 13.9% | ||

GM | 32.81% |

OM growth 3Y13.39%

OM growth 5Y9.89%

PM growth 3Y12.63%

PM growth 5Y7.7%

GM growth 3Y4.8%

GM growth 5Y3.26%

There is no outstanding debt for **CSL**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

An Altman-Z score of **5.64** indicates that **CSL** is not in any danger for bankruptcy at the moment.

With a decent **Altman-Z score** value of **5.64**, **CSL** is doing good in the industry, outperforming **71.11%** of the companies in the same industry.

A Debt/Equity ratio of **0.78** indicates that **CSL** is somewhat dependend on debt financing.

Although **CSL** does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.78 | ||

Debt/FCF | 2.15 | ||

Altman-Z | 5.64 |

ROIC/WACC1.33

WACC10.98%

With an excellent **Current ratio** value of **4.18**, **CSL** belongs to the best of the industry, outperforming **88.89%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 4.18 | ||

Quick Ratio | 3.73 |

Measured over the past years, **CSL** shows a very strong growth in **Earnings Per Share**. The EPS has been growing by **32.04%** on average per year.

The **Revenue** has decreased by **-7.57%** in the past year.

The **Revenue** has been growing by **11.94%** on average over the past years. This is quite good.

EPS 1Y (TTM)-13.9%

EPS 3Y34.53%

EPS 5Y32.04%

EPS growth Q2Q-17.31%

Revenue 1Y (TTM)-7.57%

Revenue growth 3Y11.06%

Revenue growth 5Y11.94%

Revenue growth Q2Q-29.78%

Based on estimates for the next years, **CSL** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-0.99%** on average per year.

EPS Next Y-25.13%

EPS Next 2Y-6.22%

EPS Next 3Y-0.99%

EPS Next 5YN/A

Revenue Next Year-30.94%

Revenue Next 2Y-14.96%

Revenue Next 3Y-9.22%

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

A **Price/Earnings** ratio of **21.43** indicates a rather expensive valuation of **CSL**.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 21.43 | ||

Fwd PE | 19.92 |

The rest of the industry has a similar **Enterprise Value to EBITDA** ratio as **CSL**.

The rest of the industry has a similar **Price/Free Cash Flow** ratio as **CSL**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 16.01 | ||

EV/EBITDA | 14.33 |

PEG (NY)N/A

PEG (5Y)0.67

EPS Next 2Y-6.22%

EPS Next 3Y-0.99%

With a yearly dividend of 0.98%, **CSL** is not a good candidate for dividend investing.

Compared to an average S&P500 **Dividend Yield** of **2.48**, **CSL**'s dividend is way lower than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.98% |

On average, the dividend of **CSL** grows each year by **12.36%**, which is quite nice.

Dividend Growth(5Y)12.36%

Div Incr Years15

Div Non Decr Years15

DP18.89%

EPS Next 2Y-6.22%

EPS Next 3Y-0.99%

**CARLISLE COS INC**

NYSE:CSL (2/22/2024, 11:36:09 AM)

**350.315**

**+2.88 (+0.83%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryBuilding Products

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap17.05B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.98% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 21.43 | ||

Fwd PE | 19.92 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.67

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 12.28% | ||

ROE | 28.63% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 18.3% | ||

PM (TTM) | 13.9% | ||

GM | 32.81% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.88

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.78 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 4.18 | ||

Quick Ratio | 3.73 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-13.9%

EPS 3Y34.53%

EPS 5Y

EPS growth Q2Q

EPS Next Y-25.13%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-7.57%

Revenue growth 3Y11.06%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y